Ouyang Y, Li J
Medicine (Baltimore). 2025; 104(9):e41495.
PMID: 40020133
PMC: 11875627.
DOI: 10.1097/MD.0000000000041495.
Elias A, Das S, Kirkland J, Loyal S, Thomas N
PCN Rep. 2025; 4(1):e70051.
PMID: 39759458
PMC: 11695668.
DOI: 10.1002/pcn5.70051.
Lapid M, Merrill J, Mueller M, Hermida A, Nykamp L, Andrus J
PLoS One. 2024; 19(6):e0303894.
PMID: 38941338
PMC: 11213353.
DOI: 10.1371/journal.pone.0303894.
Sadek J, Diaz-Piedra B, Saleh L, MacDonald L
Front Psychiatry. 2024; 15:1395462.
PMID: 38800059
PMC: 11117711.
DOI: 10.3389/fpsyt.2024.1395462.
Akhtar S, Saleem S, Rizvi S, Raja S, Asghar M
Front Neurol. 2023; 14:1251882.
PMID: 37915381
PMC: 10616260.
DOI: 10.3389/fneur.2023.1251882.
Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression.
Kaurani L, Besse M, Methfessel I, Methi A, Zhou J, Pradhan R
Transl Psychiatry. 2023; 13(1):294.
PMID: 37699900
PMC: 10497550.
DOI: 10.1038/s41398-023-02582-4.
Impact of modeled field of view in electroconvulsive therapy current flow simulations.
Guillen A, Abbott C, Deng Z, Huang Y, Pascoal-Faria P, Truong D
Front Psychiatry. 2023; 14:1168672.
PMID: 37275969
PMC: 10232815.
DOI: 10.3389/fpsyt.2023.1168672.
Rocuronium action can be affected by hyperventilation: a case report and computational simulation.
Taguchi S, Fujimoto D, Shiga M, Obata N, Mizobuchi S
J Clin Monit Comput. 2023; 37(4):1115-1118.
PMID: 37138040
DOI: 10.1007/s10877-023-01022-4.
Association between electroconvulsive therapy and depressive disorder from 2012 to 2021: Bibliometric analysis and global trends.
Cai H, Du R, Yang K, Li W, Wang Z
Front Hum Neurosci. 2022; 16:1044917.
PMID: 36457756
PMC: 9706542.
DOI: 10.3389/fnhum.2022.1044917.
Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives....
Henstra M, Feenstra T, Kok R, Spaans H, van Exel E, Dols A
Front Psychiatry. 2022; 13:953686.
PMID: 35911242
PMC: 9334653.
DOI: 10.3389/fpsyt.2022.953686.
The Effects of Baseline Impaired Global Cognitive Function on the Efficacy and Cognitive Effects of Electroconvulsive Therapy in Geriatric Patients: A Retrospective Cohort Study.
Luccarelli J, Forester B, Dooley M, Patrick R, Harper D, Seiner S
Am J Geriatr Psychiatry. 2022; 30(7):790-798.
PMID: 34996701
PMC: 9177530.
DOI: 10.1016/j.jagp.2021.12.008.
Effects of Reflexology on the Pain Intensity among Patients with Depression after Receiving Electroconvulsive Therapy: A Randomized Clinical Trial.
Aliashraf Jodat M, Alilu L, Ahangarzadeh Rezayee S, Asl R
J Caring Sci. 2021; 10(3):129-136.
PMID: 34849356
PMC: 8609114.
DOI: 10.34172/jcs.2021.007.
The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression.
Loef D, Vansteelandt K, Oudega M, van Eijndhoven P, Carlier A, van Exel E
Brain Behav Immun Health. 2021; 18:100389.
PMID: 34841285
PMC: 8607155.
DOI: 10.1016/j.bbih.2021.100389.
Transcranial magnetic stimulation (TMS) for geriatric depression.
Cappon D, den Boer T, Jordan C, Yu W, Metzger E, Pascual-Leone A
Ageing Res Rev. 2021; 74:101531.
PMID: 34839043
PMC: 8996329.
DOI: 10.1016/j.arr.2021.101531.
Late Life Depression: The Essentials and the Essential Distinctions.
Husain-Krautter S, Ellison J
Focus (Am Psychiatr Publ). 2021; 19(3):282-293.
PMID: 34690594
PMC: 8475940.
DOI: 10.1176/appi.focus.20210006.
Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (Review).
Trifu S, Sevcenco A, Stanescu M, Dragoi A, Cristea M
Exp Ther Med. 2021; 22(5):1281.
PMID: 34630636
PMC: 8461517.
DOI: 10.3892/etm.2021.10716.
A Narrative Overview of Current Anesthetic Drugs in Electroconvulsive Therapy.
Lee K, Jenkins K, Sparkle T
Life (Basel). 2021; 11(9).
PMID: 34575130
PMC: 8466199.
DOI: 10.3390/life11090981.
Electroconvulsive Therapy and Age: Effectiveness, Safety and Tolerability in the Treatment of Major Depression among Patients under and over 65 Years of Age.
Dominiak M, Antosik-Wojcinska A, Wojnar M, Mierzejewski P
Pharmaceuticals (Basel). 2021; 14(6).
PMID: 34207157
PMC: 8234688.
DOI: 10.3390/ph14060582.
Rate of continuing acute course treatment using right unilateral ultrabrief pulse electroconvulsive therapy at a large academic medical center.
Luccarelli J, McCoy Jr T, Shannon A, Forester B, Seiner S, Henry M
Eur Arch Psychiatry Clin Neurosci. 2020; 271(1):191-197.
PMID: 33196856
PMC: 7867629.
DOI: 10.1007/s00406-020-01202-2.
Demographics of Patients Receiving Electroconvulsive Therapy Based on State-Mandated Reporting Data.
Luccarelli J, Henry M, McCoy Jr T
J ECT. 2020; 36(4):229-233.
PMID: 32453188
PMC: 7677170.
DOI: 10.1097/YCT.0000000000000692.